Concepedia

Uwe Thuß

UT

Statistics

Publications

2

Citations

50

H-Index

2

Active since

2018

Affiliations

Bayer (Germany)(Current)

Clinical Research Services

Uwe Thuß is an author at Bayer (Germany) specializing in relative oral bioavailability, pharmacy, and clinical pharmacology.

ORCID

Publications per year

2018–2022

2

Publications

2

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers

Friederike Kanefendt, Uwe Thuß, Michael Becka et al. · Clinical Pharmacology in Drug Development · 2018 · 27 citations

, , +13

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

Stefan Klein, Isabella Gashaw, Sybille Baumann et al. · British Journal of Clinical Pharmacology · 2022 · 23 citations · Full text

, , +9

1–2 of 2